Indications and uses
For prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness
For prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness
Do not exceed recommended dosage. To prevent motion sickness; take the first dose one hour before starting activity. Adults and children 12 years of age and over: 1 to 2 tablets once daily, or as directed by a doctor.
Drug Facts
Meclizine 25 mg
Antiemetic
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
If pregnant or breast-feeding,
Keep out of reach of children.
In case of accidental overdose, seek medical help or contact a Poison Control Center immediately. 1-800-222-1222
Do not exceed recommended dosage.
To prevent motion sickness; take the first dose one hour before starting activity.
| Adults and children 12 years of age and over: | 1 to 2 tablets once daily, or as directed by a doctor. |
Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate
Call 1-205-313-8298
Manufactured for
The Generic Pharmaceutical Company, Inc.
Leeds, AL 35094
NDC 57963-101-01
100 Tablets
Meclizine 25
Antiemetic
Each immediate-release tablet contains:
Meclizine HCl
25 mg
Store at 59°-86°F (15°-30°C)
[see USP Controlled Room Temperature].
Tamper evident by foil seal under cap.
Do not use if foil seal is broken or missing.
Manufactured for
The Generic Pharmaceutical Company, Inc.
Leeds, AL 35094

| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57963-101-01 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-4e21-a426-e053-dadaa90af4c2 | Meclizine 25 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57963-101-01 | Meclizine 25 | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57963-101-01 | EA - Each | 57963-101 | b2addbf7-78a0-406a-82de-d32ccf89f5fc | 1 | 2017-03-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57963-101 | 57963-101-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
| Magnesium Stearate | 70097M6I30 | IACT |
| Microcrystalline Cellulose | OP1R32D61U | IACT |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | 5856J3G2A2 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6eafa4df-b743-4c70-9fe1-97c30b07d82d | b13cb390-20ed-43ce-aa74-5a754539f6e2 | 2017-01-09 | Warnings | 6eafa4df-b743-4c70-9fe1-97c30b07d82d b13cb390-20ed-43ce-aa74-5a754539f6e2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.